Cargando…

Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity

INTRODUCTION: The aim of our study was to evaluate the diagnostic characteristics of selected inflammatory markers and the results of multiplication of their concentrations in the diagnosis and assessment of Crohn’s disease (CD) activity. METHODS: We studied 49 patients with CD and 31 healthy contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Słowińska-Solnica, Krystyna, Pawlica-Gosiewska, Dorota, Gawlik, Katarzyna, Owczarek, Danuta, Cibor, Dorota, Pocztar, Halina, Mach, Tomasz, Solnica, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811324/
https://www.ncbi.nlm.nih.gov/pubmed/33488879
http://dx.doi.org/10.5114/aoms/130842
_version_ 1783637474296201216
author Słowińska-Solnica, Krystyna
Pawlica-Gosiewska, Dorota
Gawlik, Katarzyna
Owczarek, Danuta
Cibor, Dorota
Pocztar, Halina
Mach, Tomasz
Solnica, Bogdan
author_facet Słowińska-Solnica, Krystyna
Pawlica-Gosiewska, Dorota
Gawlik, Katarzyna
Owczarek, Danuta
Cibor, Dorota
Pocztar, Halina
Mach, Tomasz
Solnica, Bogdan
author_sort Słowińska-Solnica, Krystyna
collection PubMed
description INTRODUCTION: The aim of our study was to evaluate the diagnostic characteristics of selected inflammatory markers and the results of multiplication of their concentrations in the diagnosis and assessment of Crohn’s disease (CD) activity. METHODS: We studied 49 patients with CD and 31 healthy controls. The CD patients were assigned to subgroups with active and inactive disease based on the Crohn’s Disease Activity Index score. Serum interleukins and C-reactive protein (CRP) were measured using immunoassays. RESULTS: Serum CRP and interleukins: IL-6, IL-17A, IL-23 were significantly higher in the CD group than in controls, with the best diagnostic performance for IL-23. Only serum IL-6 and CRP were significantly higher in active than in inactive disease, with the better performance of CRP. Multiplication results did not perform better than individual multipliers. CONCLUSIONS: Serum CRP may be useful in the assessment of CD activity and there is a need for introduction of IL-23 for the CD diagnosis.
format Online
Article
Text
id pubmed-7811324
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-78113242021-01-22 Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity Słowińska-Solnica, Krystyna Pawlica-Gosiewska, Dorota Gawlik, Katarzyna Owczarek, Danuta Cibor, Dorota Pocztar, Halina Mach, Tomasz Solnica, Bogdan Arch Med Sci Research Letter INTRODUCTION: The aim of our study was to evaluate the diagnostic characteristics of selected inflammatory markers and the results of multiplication of their concentrations in the diagnosis and assessment of Crohn’s disease (CD) activity. METHODS: We studied 49 patients with CD and 31 healthy controls. The CD patients were assigned to subgroups with active and inactive disease based on the Crohn’s Disease Activity Index score. Serum interleukins and C-reactive protein (CRP) were measured using immunoassays. RESULTS: Serum CRP and interleukins: IL-6, IL-17A, IL-23 were significantly higher in the CD group than in controls, with the best diagnostic performance for IL-23. Only serum IL-6 and CRP were significantly higher in active than in inactive disease, with the better performance of CRP. Multiplication results did not perform better than individual multipliers. CONCLUSIONS: Serum CRP may be useful in the assessment of CD activity and there is a need for introduction of IL-23 for the CD diagnosis. Termedia Publishing House 2021-01-05 /pmc/articles/PMC7811324/ /pubmed/33488879 http://dx.doi.org/10.5114/aoms/130842 Text en Copyright: © 2021 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Research Letter
Słowińska-Solnica, Krystyna
Pawlica-Gosiewska, Dorota
Gawlik, Katarzyna
Owczarek, Danuta
Cibor, Dorota
Pocztar, Halina
Mach, Tomasz
Solnica, Bogdan
Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title_full Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title_fullStr Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title_full_unstemmed Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title_short Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
title_sort serum inflammatory markers in the diagnosis and assessment of crohn’s disease activity
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811324/
https://www.ncbi.nlm.nih.gov/pubmed/33488879
http://dx.doi.org/10.5114/aoms/130842
work_keys_str_mv AT słowinskasolnicakrystyna seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT pawlicagosiewskadorota seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT gawlikkatarzyna seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT owczarekdanuta seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT cibordorota seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT pocztarhalina seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT machtomasz seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity
AT solnicabogdan seruminflammatorymarkersinthediagnosisandassessmentofcrohnsdiseaseactivity